Inpatient medication vertification by pharmacy student

合集下载

医学护理专业英语词汇大全

医学护理专业英语词汇大全

医学护理专业英语词汇大全1. Medical Nursing: 医学护理2. Nursing: 护理3. Patient: 病人4. Doctor: 医生5. Nurse: 护士6. Healthcare: 医疗保健7. Hospital: 医院8. Clinic: 诊所9. Emergency: 急诊10. Ward: 病房11. Operating Room: 手术室12. Intensive Care Unit (ICU): 重症监护室13. Neonatal Intensive Care Unit (NICU): 新生儿重症监护室14. Outpatient: 门诊病人15. Inpatient: 住院病人16. Diagnosis: 诊断17. Treatment: 治疗18. Medication: 药物19. Surgery: 手术20. Anesthesia: 麻醉21. Rehabilitation: 康复22. Palliative Care: 缓解治疗23. Vital Signs: 生命体征24. Blood Pressure: 血压25. Heart Rate: 心率26. Respiratory Rate: 呼吸率27. Temperature: 温度28. Oxygen Saturation: 血氧饱和度29. Pain Assessment: 疼痛评估30. Wound Care: 创伤护理31. Infection Control: 感染控制32. Fall Prevention: 跌倒预防33. Medication Administration: 药物管理34. Intravenous (IV) Therapy: 静脉注射疗法35. Intramuscular (IM) Injection: 肌肉注射36. Subcutaneous (SC) Injection: 皮下注射37. Oral Medication: 口服药物38. Intravenous Fluids: 静脉输液39. Oxygen Therapy: 氧气疗法40. Catheterization: 导尿41. Urinary Catheter: 尿管42. Feeding Tube: 饲管43. Ostomy Care: 建造护理44. Enteral Nutrition: 肠道营养45. Respiratory Therapy: 呼吸治疗46. Physical Therapy: 物理疗法47. Occupational Therapy: 职业疗法48. Speech Therapy: 言语疗法49. Mental Health: 心理健康50. Dementia Care: 痴呆护理。

国际药物注册英语词汇

国际药物注册英语词汇

国际药物注册英语词汇互译FDA(food and drug administration):(美国)食品药品监督管理局NDA(new drug application):新药申请ANDA(abbreviated new drug application):简化新药申请EP(export application):出口药申请(申请出口不被批准在美国销售的药品)treatment IND:研究中的新药用于治疗abbreviated(new)drug:简化申请的新药DMF(drug master file):药物主文件(持有者为谨慎起见而准备的保密资料,可以包括一个或多个人用药物在制备、加工、包装和贮存过程中所涉及的设备、生产过程或物品。

只有在DMF持有者或授权代表以授权书的形式授权给FDA,FDA在审查IND、NDA、ANDA时才能参考其内容)holder:DMF持有者CFR(code of federal regulation):(美国)联邦法规PANEL:专家小组batch production:批量生产;分批生产batch production records:生产批号记录post or pre-market surveillance:销售前或销售后监督informed consent:知情同意(患者对治疗或受试者对医疗试验了解后表示同意接受治疗或试验)prescription drug:处方药OTC drug(over—the—counter drug):非处方药U.S. public health service:美国卫生福利部NIH(national institute of health):(美国)全国卫生研究所animal trail:动物试验accelerated approval:加速批准standard drug:标准药物investigator :研究人员;调研人员preparing and submitting:起草和申报submission:申报;递交benefit(s):受益risk(s):受害drug product:药物产品drug substance:原料药established name:确定的名称generic name:非专利名称proprietary name:专有名称;INN(international nonproprietary name):国际非专有名称narrative summary: 记叙体概要adverse effect:副作用adverse reaction:不良反应protocol:方案archival copy:存档用副本review copy:审查用副本official compendium:法定药典(主要指USP、NF).USP(the united state pharmacopeia):美国药典(现已和NF合并一起出版)NF(national formulary):(美国)国家药品集official=pharmacopeial = compendial:药典的;法定的;官方的agency:审理部门(指FDA)sponsor:主办者(指负责并着手临床研究者)identity:真伪;鉴别;特性strength:规格;规格含量(每一剂量单位所含有效成分的量)labeled amount:标示量regulatory specification:质量管理规格标准(NDA提供)regulatory methodology:质量管理方法(FDA用于考核原料药或药物产品是否符合批准了的质量管理规格标准的整套步骤)regulatory methods validation:管理用分析方法的验证(FDA对NDA提供的方法进行验证)Dietary supplement:食用补充品ICH(International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use)人用药物注册技术要求国际协调会议ICH:Quality-质量Q1A(R2): Stability Testing of New Drug Substances and Products (SecondRevision)新原料药和制剂的稳定性试验(第二版)Q1B: Photostability Testing of New Drug Substances and Products新原料药和制剂的光稳定性试验Q1C: Stability Testing for New Dosage Forms新制剂的稳定性试验Q1D: Bracketing and Matrixing Designs for Stability Testing of Drug Substances and Drug Products原料药和制剂稳定性试验的交叉和矩阵设计Q1E: Evaluation of Stability Data对稳定性数据的评估处理Q1F: Stability Data Package for Registration Applications in Climatic Zones III and IV在气候带III和IV,药物注册申请所提供的稳定性数据Q2A: Text on Validation of Analytical Procedures分析程序的验证Q2B: Validation of Analytical Procedures: Methodology分析程序的验证:方法学Q3A(R): Impurities in New Drug Substances (Revised Guideline)新原料药中的杂质(修订版)Q3B(R): Impurities in New Drug Products (Revised Guideline)新制剂中的杂质(修订版)Q3C: Impurities: Guideline for Residual Solvents杂质:残留溶剂指南Q3C(M): Impurities: Guideline for Residual Solvents (Maintenance)杂质:残留溶剂指南(修改内容)Q4: Pharmacopoeias药典Q4A: Pharmacopoeial Harmonisation 药典的协调Q4B: Regulatory Acceptance of Pharmacopoeial Interchangeability药典互替在法规上的可接受性Q5A: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin来源于人或者动物细胞系的生物技术产品的病毒安全性评估Q5B: Quality of Biotechnological Products: Analysis of the ExpressionConstruct in Cells Used for Production of r-DNA Derived Protein Products生物技术产品的质量:源于重组DNA的蛋白质产品的生产中所用的细胞中的表达构建分析Q5C: Quality of Biotechnological Products: Stability Testing ofBiotechnological/Biological Products生物技术产品的质量:生物技术/生物产品的稳定性试验Q5D: Derivation and Characterisation of Cell Substrates Used forProduction of Biotechnological/Biological Products用于生产生物技术/生物产品的细胞底物的起源和特征描述Q5E: Comparability of Biotechnological/Biological Products Subject toChanges in Their Manufacturing Process基于不同生产工艺的生物技术产品/生物产品的可比较性Q6: Specifications for New Drug Substances and Products新原料药和制剂的质量规格Q6A: Specifications: Test Procedures and Acceptance Criteria for New DrugSubstances and New Drug Products: Chemical Substances质量规格:新原料药和新制剂的检验程序和可接收标准:化学物质Q6B: Specifications: Test Procedures and Acceptance Criteria forBiotechnological/Biological Products质量规格:生物技术/生物产品的检验程序和可接收标准Q7: Good Manufacturing Practices for Pharmaceutical Ingredients活性药物成份的GMPQ7A: Good Manufacturing Practice Guide for Active PharmaceuticalIngredients活性药物成份的GMP指南Q8: Pharmaceutical Development药物研发Q9: Quality Risk Management质量风险管理ICH:Safety-安全S1A: Guideline on the Need for Carcinogenicity Studies of Pharmaceuticals药物致癌性研究需要的指南S1B: Testing for Carcinogenicity of Pharmaceuticals药物致癌性的检验S1C: Dose Selection for Carcinogenicity Studies of Pharmaceuticals药物致癌性研究之剂量选择S1C(R): Addendum: Addition of a Limit Dose and Related Notes附录:极限剂量和有关注释的的补充S2A: Guidance on Specific Aspects of Regulatory Genotoxicity Tests forPharmaceuticals受法规管辖的药物基因毒性检验的特定方面的指南S2B: Genotoxicity: A Standard Battery for Genotoxicity Testing forPharmaceuticals基因毒性:药物基因毒性检验的标准S3A: Note for Guidance on Toxicokinetics: The Assessment of SystemicExposure in Toxicity Studies毒物代谢动力学指南的注释:毒性研究中的全身性暴露量的评估S3B: Pharmacokinetics: Guidance for Repeated Dose Tissue DistributionStudies药物代谢动力学:重复剂量的组织分布研究指南S4: Single Dose Toxicity Tests单剂量毒性检验S4A: Duration of Chronic Toxicity Testing in Animals (Rodent andNon-Rodent Toxicity Testing)动物体内慢性毒性持续时间的检验(啮齿动物和非啮齿动物毒性检验)S5A: Detection of Toxicity to Reproduction for Medicinal Products药物对生殖发育的毒性的检验S5B(M): Maintenance of the ICH Guideline on Toxicity to Male Fertility:An Addendum to the Guideline on Detection of Toxicity to Reproduction forMedicinal Products对男性生殖能力的毒性的指南的变动:药物对生殖发育的毒性的检验指南增加了一个附录S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals生物技术生产的药物的临床前安全评价S7A: Safety Pharmacology Studies for Human Pharmaceuticals人用药的安全药理学研究S7B: The Nonclinical Evaluation of the Potential for Delayed VentricularRepolarization(QT Interval Prolongation) By Human Pharmaceuticals药物延迟心室复极化(QT间期)潜在作用的非临床评价S8: Immunotoxicology Studies for Human Pharmaceuticals人用药免疫毒理学研究M3(M): Maintenance of the ICH Guideline on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals药物的对人临床试验的非临床安全研究指南的变动E-Efficacy(有效)E1: The Extent of Population Exposure to Assess Clinical Safety for DrugsIntended for Long-Term Treatment of Non-Life-Threatening Conditions对用于无生命危险情况下长期治疗的药物进行临床安全评估的族群暴露量范围E2A: Clinical Safety Data Management: Definitions and Standards forExpedited Reporting临床安全数据管理:速报制度的定义和标准E2B(R): Revision of the E2B(M) ICH Guideline on Clinical Safety DataManagement Data Elements for Transmission of Individual Case Safety Reports个案安全报告送交的临床安全数据管理的数据要素指南(E2B(M))的修订版E2B (M): Maintenance of the Clinical Safety Data Management including:Data Elements for Transmission of Individual Case Safety Reports临床安全数据管理的变动包括:个案安全报告送交的数据要素E2B(M): Maintenance of the Clinical Safety Data Management includingQuestions and Answers临床安全数据管理的变动,包括问答E2C: Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs临床安全数据管理:已上市药品的周期性安全数据更新报告Addendum to E2C: Periodic Safety Update Reports for Marketed DrugsE2C的附录:已上市药品的周期性安全数据更新报告E2D: Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting批准后的安全数据管理:速报制度的定义和标准E2E: Pharmacovigilance Planning药物警戒计划E3: Structure and Content of Clinical Study Reports临床研究报告的结构和内容E4: Dose-Response Information to Support Drug Registration支持药品注册的剂量-效应资料E5: Ethnic Factors in the Acceptability of Foreign Clinical Data引入海外临床数据时要考虑的人种因素E6: Good Clinical Practice: Consolidated GuidelineGCP:良好的临床规范:统一的指南E7: Studies in Support of Special Populations: Geriatrics对特定族群的支持的研究:老人病学E8: General Considerations for Clinical Trials对临床试验的总的考虑E9: Statistical Principles for Clinical Trials临床试验的统计原则E10: Choice of Control Group and Related Issues in Clinical Trials临床试验中控制组和有关课题的选择E11: Clinical Investigation of Medicinal Products in the Pediatric Population小儿科药物的临床调查E12A: Principles for Clinical Evaluation of New Antihypertensive Drugs新抗高血压药物的临床评价原则E14: The Clinical Evaluation of QT/QTc Interval Prolongation andProarrhythmic Potential for Non-Antiarrhythmic Drugs非抗心率失常药物的QT/QTc 间期和致心率失常潜在作用的临床评价Multidisciplinary Guidelines 多学科兼容的指南M1: Medical Terminology医学术语M2: Electronic Standards for Transmission of Regulatory Information (ESTRI)药政信息传递之电子标准M3: Timing of Pre-clinical Studies in Relation to Clinical Trials (SeeSafety Topics)有关临床试验的临床前研究的时间安排M4: The Common Technical Document (See CTD section for complete Status ofthe guidelines)通用技术文件(见有关CTD章节)M5: Data Elements and Standards for Drug Dictionaries药物词典的数据要素和标准临床试验常用的英文缩略语TTP:time-to-progression 疾病进展时间SAE:severity Adverse Event 严重不良事件AE:Adverse Event 不良事件SOP:Standard Operating Procedure 标准操作规程CRF:Case Report form 病例报告表DLT:剂量限制毒性MTD:最大耐受剂量KPS:Karnofsky Performance Status行为状态评分CR:complete response完全缓解PR:partial response部分缓解SD:病情稳定PD:progressive disease病情进展CTC:常用药物毒性标准IEC:independent ethics committee 独立伦理委员会IRB :institutional review board 伦理委员会CRA:临床研究助理CRO:Contract Research Organization 合同研究组织DFS:Disease Free Survival 无病生存期OS:(Overall Survival)总生存时间IC:Informed consent 知情同意ADR:Adverse Drug Reaction 不良反应GAP:Good Agricultural Practice 中药材种植管理规范GCP:Good Clinical Practice 药物临床试验质量管理规范GLP:Good Laboratory Practice 药品实验室管理规范GMP:Good Manufacturing Practice 药品生产质量管理规范GSP:Good Supply Practice 药品经营质量管理规范GUP:Good Use Practice 药品使用质量管理规范PI :Principal investigator 主要研究者CI:Co-inveatigator 合作研究者SI :Sub-investigator 助理研究者COI :Coordinating investigtor 协调研究者国际药物注册英语词汇DGMP:医疗器械生产质量管理规范ICF:Informed consent form 知情同意书RCT :randomized controlled trial, 随机对照试验NRCCT:non-randomized concurrent controlled trial, 非随机同期对照试验EBM:evidence-based medicine 循证医学RCD:randomized cross-over disgn 随机交叉对照试验HCT:historial control trial, 历史对照研究RECIST:Response Evaluation Criteria In Solid Tumors. 实体瘤疗效反应的评价标准QC:Quality Control质量控制UADR:Unexpected Adverse Drug Reaction,非预期药物不良反应11 / 11。

清单式管理在降低内科住院患者口服药不良事件发生率中的应用

清单式管理在降低内科住院患者口服药不良事件发生率中的应用

清单式管理在降低内科住院患者口服药不良事件发生率中的应用【摘要】目的探讨清单式管理在降低内科住院患者口服药不良事件发生率中的应用效果。

方法为减少口服药不良事件发生,对我院2019年1-6月份使用口服药治疗的1265例内科住院患者中,发生的18例口服药不良事件进行回顾性分析,汇总口服药不良事件的责任主体和发生原因。

对2019年7-12月份使用口服药治疗的1322例内科住院患者中,实施清单式管理措施。

对使用清单式管理后口服药不良事件发生率与1-6月份进行对比分析。

结果 2019年7-12月份使用口服药治疗的1322例内科住院患者发生口服药不良事件6例,发生率为0.45%;2019年1-6月份使用口服药治疗的1265例内科住院患者发生口服药不良事件18例,发生率为1.42%。

两者进行比较,差异具有统计学意义(P<0.05)。

结论在内科住院患者使用口服药过程中,实施清单式管理,能有效降低口服药不良事件发生率,有效保障患者口服用药安全和口服药物治疗的连续性,促进患者康复。

【关键词】清单式管理;内科住院患者;口服药不良事件发生率【 Abstract 】 Objective To explore the application effect of checklist management in reducing the incidence of oral adverse events in internal medicine inpatients. Methods In order to reduce the occurrence of adverse events of oral medicine, 18 cases of adverse events of oral medicine were retrospectively analyzed among 1265 inpatients treated with oral medicine in our hospital from January to June 2019, and the responsible subjects and causes of adverse events of oral medicine were summarized. Checklist management measures were implemented among 1322 inpatients who were treated with oral medicine from July to December 2019. The incidence of adverse events of oralmedicine after the use of checklist management was compared with thatin January to June. Results From July to December 2019, 6 cases (0.45%) of 1322 inpatients treated with oral medicine had adverse events. From January to June 2019, 18 cases of oral adverse events occurred among 1265 inpatients treated with oral medicine, with an incidence of 1.42%. The difference was statistically significant (P<0.05). Conclusion Inthe process of oral medication use in internal medicine inpatients,the implementation of checklist management can effectively reduce the incidence of oral medication adverse events, effectively guarantee the safety of oral medication continuity, and promote the recovery of patients.【 Key words 】 List management; Internal medicine inpatient; Incidence of oral adverse events在内科住院病人中,大多数为老年慢性病患者,需长期服用多种口服药。

出院带药闭环管理系统的开发与应用

出院带药闭环管理系统的开发与应用
为了提高调配效率、提升药事服务质量,实现 出院带药全程监管和用药安全,在不大幅增加硬件 成本建设物流轨道的情况下,我们主导设计开发出
234 CHINA MEDICINE AND PHARMACY Vol.11 No.12 June 2021
2021年6月第11卷第12期
·工作探讨·
院带药闭环管理系统,通过 SPD 和条码化实现流 程节点数据化和可追溯的闭环管理。该系统采用 JAVA 语 言 通 过 WebService 技 术,实 现 与 HIS 系 统的数据交互。药房调剂环节通过多串口的应用 和 语 音 提 示,实 现 同 时 记 录 医 嘱 信 息、操 作 人、时 执行间,操作便捷高效。采用 web 端页面实现护士 站签收,与 HIS 系统对接,页面连接采用 HTTP 请 求 的 方 式 传 入 操 作 人 等 信 息,实 现 了 医 嘱 各 流 转 节点的信息的记录。在统计查询页面上采用 Ajax 技 术,实 现 数 据 动 态 追 踪、流 程 节 点 数 据 统 计、查 询和导出。
出院带药是住院患者就医的最后一个环节,患者 取药等候时间较长则影响就医获得感和满意度。随 着信息技术及智能设备在医药领域的广泛应用,药学 服务效率和质量得到了快速提高 [1-2]。三级公立医院 绩效考核体系中患者就医满意度是其中一个重要维 度,我院高度重视这次考评,持续开展了系列“暖心行 动计划”活动,不断改进患者就医流程,办患者满意的 医院。为进一步改善服务质量,使日常工作流程更加 精细化和科学化 [3],我们主导设计开发出院带药闭环 管理系统,构建适合我院出院带药服务流程的状态可 追溯,质量可控制的管理平台,现报道如下。 1 原出院带药服务流程存在的问题
2021年6月第11卷第12期
配送时长进行监测分析,通过管理手段采取弹性排 班等方式,优化各岗位人员配置,使人力资源最大 化 利 用;时 长 数 据 结 合 人 员 岗 位 工 作 量 及 差 错 情 况,制定服务质量可量化的绩效考核方案,可提高 工作积极性及服务效率。见图 5。

门诊处方调剂的正确流程

门诊处方调剂的正确流程

门诊处方调剂的正确流程英文回答:Prescription Dispensing Process in Outpatient Settings.1. Verification of Prescription.Verify patient's identity (e.g., by photo ID or verbally).Inspect the prescription for completeness and accuracy (e.g., patient name, date, medication name, dosage, route of administration, frequency, refills).Check for any potential drug interactions, allergies, or contraindications.2. Preparation of Medication.Retrieve the prescribed medication from the pharmacyinventory.Double-check the medication label against the prescription.Measure and dispense the correct dosage and quantity.Ensure that the medication is dispensed in a safe and tamper-proof container.3. Labeling and Packaging.Label the medication container clearly with the following information:Patient name.Medication name.Dosage.Route of administration.Frequency.Refills.Expiration date.Storage instructions.Provide any necessary patient education materials (e.g., medication guide, instructions for use).4. Counseling and Documentation.Counsel the patient on the medication's use, storage, and potential side effects.Answer any questions the patient may have.Document the dispensing process thoroughly in the patient's medical record.5. Follow-up.If necessary, schedule a follow-up appointment to monitor the patient's response to the medication.Inquire about any adverse events or concerns the patient may have.中文回答:门诊处方调剂的正确流程。

全自动片剂摆药机使用中存在的风险及管控方法

全自动片剂摆药机使用中存在的风险及管控方法

全自动片剂摆药机使用中存在的风险及管控方法目的:提高医院住院药房全自动片剂摆药机的摆药准确率。

方法:分析我院住院药房使用全自动片剂摆药机过程中存在的风险并总结对应的管控方法。

结果与结论:我院住院药房从备药、剥药、补药、医嘱审核等全自动片剂摆药机使用过程中的各个环节进行了有效的风险管控,同时,还加强了拆零药品的规范管理,规范了药盒标注,定期对全自动片剂摆药机进行维护与保养,建立了相关制度及标准操作规程,规范了人员培训及考核体系,从而大大减少了差错的发生,确保了患者的用药安全。

ABSTRACT OBJECTIVE:To improve accuracy rate of automatic tablet dispensing machine in the inpatient pharmacy. METHODS:The risks and corresponding control methods in the use of automatic tablet dispensing machine in inpatient pharmacy of our hospital were summarized and analyzed. RESULTS & CONCLUSIONS:Effective risk control was carried out in the inpatient pharmacy of our hospital in the respects of drug preparation,drug stripping,drug supplement and medical order examination. At the same time,it also strengthened the standardized management of unpacked medicines,standardized the labeling of medicine boxes,regularly maintained the automatic tablet dispensing machine,established related system and standard operation procedure and standardized staff training and examination system,which reduced the occurrence of errors and ensured the safety of patients’medication.KEYWORDS Automatic tablet dispensing machine;Multi-link control;Risk control;Medication safety在倡导”以患者为中心”的药学服务模式下,药品调剂工作的模式也正在由传统的配方发药向全面的药学服务转变。

我院住院患者头孢哌酮舒巴坦临床应用评价

我院住院患者头孢哌酮舒巴坦临床应用评价

Evaluation of cefoperazone/sulbactam sodium for pital

injection
in inpatients of
our
hos-
HU Dong-meil’2,ZHAO Qing.chunl・3(1.Shenyang Pharmaceutical University,Shenyang 1 10016,China; 121000,China;3.General Hospital of Shenyang Military Region,Shenyang
却更换了4种给药方案:前2天左氧氟沙星联合替 硝唑;增加头孢哌酮/舒巴坦联合用药2 d;停用左 氧氟沙星,继续用头孢哌酮/舒巴坦联合替硝唑

d;最后,将替硝唑换为奥硝唑与头孢哌酮/舒巴
坦合用l d。联合方案需要调整时,应注意保持方 案的完整性,即整体更换,而不是替换其中一种药 物;且频繁更换非但不能保证疗效,还可能增加不 良反应和医疗费用。 此外,7份手术病历存在的频繁换药问题主要 是术前应用左氧氟沙星1次,手术后更换(或联 合)头孢哌酮/舒巴坦。《通知》中规定要严格控制 氟喹诺酮类药物作为外科围手术期预防用药,氟 喹诺酮类药物仅可用于泌尿系统手术的预防感
我院住院患者头孢哌酮/舒巴坦临床应用评价
胡东梅1‘2,赵庆春1・3
随机抽取应用头孢哌酮/舒巴坦的 [摘要】 目的评价头孢哌酮/舒巴坦在临床应用的合理性。方法 121份出院病历,对其进行评价。结果 我院应用头孢哌酮/舒巴坦的突出问题体现在用药选择档次偏高(占 24.79%)。结论我院对于头孢哌酮/舒巴坦的应用存在不合理性。需规范临床医师的用t154-1"为。加强药品管理 部门的监督职责。 [关键词】 头孢哌酮/舒巴坦;合理用药;'ffi防用药;联合用药

常用护理英文术语

常用护理英文术语

常用护理英文术语在医疗领域,护理英文术语是非常重要的,它们帮助护士和其他医疗专业人员准确地传达信息和交流。

下面是一些常用的护理英文术语,供参考:1. Assessment - 评估2. Diagnosis - 诊断3. Planning - 规划4. Implementation - 实施5. Evaluation - 评价6. Vital signs - 生命体征7. Blood pressure - 血压8. Heart rate - 心率9. Respiratory rate - 呼吸速率10. Temperature - 体温11. Pain scale - 疼痛评分表12. Oxygen saturation - 血氧饱和度13. Triage - 分诊14. Transfer - 转院15. Discharge - 出院16. Inpatient - 住院患者17. Outpatient - 门诊患者18. Medical history - 病史19. Allergies - 过敏史20. Medication - 药物21. IV (intravenous) - 静脉输入22. NG tube (nasogastric tube) - 鼻胃管23. NPO (nil per os) - 空腹24. AMI (acute myocardial infarction) - 急性心肌梗塞25. CHF (congestive heart failure) - 充血性心力衰竭26. COPD (chronic obstructive pulmonary disease) - 慢性阻塞性肺疾病27. CVA (cerebrovascular accident) - 脑血管意外28. DM (diabetes mellitus) - 糖尿病29. UTI (urinary tract infection) - 尿路感染30. Wound - 创伤31. Dressing - 敷料32. IV line - 静脉输液管道33. Catheter - 导管34. IV pole - 输液支架35. Nasal cannula - 鼻导管36. Oxygen mask - 氧气面罩37. Sphygmomanometer - 血压计38. Stethoscope - 听诊器39. Syringe - 注射器40. Intramuscular injection - 肌肉注射41. Intravenous injection - 静脉注射42. Subcutaneous injection - 皮下注射43. Hypodermic needle - 注射针44. Specimen - 样本45. Urinalysis - 尿液分析46. Blood test - 血液检查47. X-ray -X光照片48. Electrocardiogram (ECG) - 心电图49. Magnetic resonance imaging (MRI) - 磁共振成像51. Ultrasound - 超声波52. Intravenous therapy - 静脉治疗53. Nebulizer - 雾化器54. Blood transfusion - 输血55. Cardiopulmonary resuscitation (CPR) - 心肺复苏56. Intensive care unit (ICU) - 重症监护室57. Operating room (OR) - 手术室58. Post-anesthesia care unit (PACU) - 麻醉后监护室59. Emergency room (ER) - 急诊室60. Diabetes management - 糖尿病管理61. Cardiac rehabilitation - 心脏康复62. Occupational therapy - 职业治疗63. Physical therapy - 物理治疗64. Speech therapy - 言语治疗65. Electronic health record (EHR) - 电子健康记录66. Hand hygiene - 手卫生67. Personal protective equipment (PPE) - 个人防护装备68. Isolation precautions - 隔离预防措施69. Standard precautions - 标准预防措施70. Fall risk assessment - 跌倒风险评估71. Pressure ulcer - 压疮72. DVT (deep vein thrombosis) - 深静脉血栓73. Nasogastric suction - 鼻胃吸引术74. Foley catheter - 弗利导尿管75. Home health care - 家庭保健以上只是一部分护理英文术语,医疗领域术语繁多,仅凭1200字无法详尽列举。

医疗卫生领域英文译写规范

医疗卫生领域英文译写规范

学习医疗卫生领域英文译写规范翻译者或者有过多次翻译行为的人,往往会比较谨慎,碰到一些名词都会考虑是否有固定译法。

对某些领域专业知识不了解,容易导致英语水平颇高的人犯“隔行如隔山”的翻译错误。

因此,对于译者而言,知识面广阔非常重要,同时也需要学习一些固定翻译的专业名词或术语。

公共服务领域英文译写规范有国标?很多领域都有相应的国际标准或国家标准,有些为人熟知,经常在广告宣传中有所耳闻,例如ISO9001。

但可能很少有人知道我国发布过GB/T 30240《公共服务领域英文译写规范》,这个国标于2017年5月22日发布,2017年12月1日实施,其中第7部分是关于医疗卫生领域的。

医疗卫生机构(health care and medical institution)是指具有医疗、预防、保健、医学教育和科研功能的单位或机构。

如何提高英文标志的准确度?现在各家医院的对外交流日益增多,很多医院的标志都是中英文双语的,但稍微看一下,很容易发现错误,有些甚至是比较低级的错误。

我国的医疗卫生机构若想提高标志文字的准确度,至少有三种方法:第一,在做标志之前认真学习这个规范,尽管它未必涵盖所有标志内容,但至少有比较大的参考价值;第二,出国研修的医务人员可以多看看英语国家医疗机构的标志是如何写的,拍照保存,再分类整理;第三,请英语国家的医疗机构工作人员审核英文译文。

附属医院和分院如何翻译?大学附属医院需要翻译出隶属关系时,“附属”译作affiliated,“附属医院”翻译方式有Affiliated Hospital of …或者Hospital Affiliated with/to;也可以省去不译,将大学名称置于医院名称之后,中间用“,”隔开。

医院的分院译作Branch Hospital,用of连接所隶属的总院名称,也可以采用“总院名称,专名+Branch”的译写方法。

专科医院名称如何翻译?专科医院一般都用最简单的单词表述。

医疗英语词汇大全掌握医疗器械及医疗服务的表达提高医疗交流能力

医疗英语词汇大全掌握医疗器械及医疗服务的表达提高医疗交流能力

医疗英语词汇大全掌握医疗器械及医疗服务的表达提高医疗交流能力医疗英语词汇大全:掌握医疗器械及医疗服务的表达,提高医疗交流能力在医疗领域进行有效的交流是医务人员和患者之间顺利沟通的基础。

为了提高医疗交流能力,掌握关键的医疗英语词汇是非常重要的。

本文将介绍一些常用的医疗器械和医疗服务的英语表达,帮助您更好地进行医疗交流。

一、医疗器械(Medical devices)1. 血压计(Blood pressure monitor)- Digital blood pressure monitor:数字血压计- Manual blood pressure monitor:手动血压计- Sphygmomanometer:血压计2. 糖尿病血糖仪(Diabetes blood glucose meter)- Blood glucose meter:血糖仪- Glucometer:血糖仪- Blood sugar monitor:血糖监测仪3. 心电图仪(Electrocardiograph)- EKG machine / ECG machine:心电图仪- Electrocardiogram machine:心电图机器4. 呼吸机(Ventilator)- Breathing machine:呼吸机- Respirator:呼吸机- Ventilator:通气机5. 手术器械(Surgical instruments)- Scalpel:解剖刀- Forceps:镊子- Surgical scissors:手术剪刀二、医疗服务(Medical services)1. 紧急医疗服务(Emergency medical services)- Ambulance:救护车- Emergency room:急诊室- CPR (Cardiopulmonary resuscitation):心肺复苏2. 门诊服务(Outpatient services)- Clinic:门诊诊所- Doctor's office:医生办公室- Consultation:会诊3. 住院服务(Inpatient services)- Hospitalization:住院- Ward:病房- Intensive care unit (ICU):重症监护室4. 检验服务(Laboratory services)- Blood test:血液检测- Urine test:尿液检测- X-ray:X射线5. 手术服务(Surgical services)- Operation:手术- Surgical procedure:外科手术- Anesthesia:麻醉三、医疗交流(Medical communication)1. 病情诊断(Diagnosis)- Physical examination:体检- Medical history:病史- Diagnosis:诊断2. 病情描述(Symptom description)- Pain:疼痛- Fever:发烧- Cough:咳嗽3. 医疗指导(Medical instructions)- Prescription:处方- Medication:药物治疗- Follow-up appointment:复诊预约4. 医患沟通(Doctor-patient communication)- Listen to the patient's concerns:倾听患者的关切- Explain the treatment plan:解释治疗计划- Provide emotional support:提供情感支持总结:通过掌握医疗器械和医疗服务的英语表达,可以提高医务人员与患者之间的交流能力。

住院药房麻醉药品发放流程

住院药房麻醉药品发放流程

住院药房麻醉药品发放流程英文回答:Inpatient Pharmacy Narcotic Dispensing Procedure.The inpatient pharmacy is responsible for the safe and secure dispensing of narcotics. The following procedure outlines the steps involved in dispensing narcotics in the inpatient setting:1. Verification of the order. The pharmacist mustverify the narcotic order before dispensing the medication. The order must be signed by a licensed prescriber and must include the patient's name, medical record number, date of birth, the name of the narcotic, the dosage, the route of administration, and the frequency of administration.2. Preparation of the medication. The pharmacist must prepare the narcotic medication according to the order. The medication must be dispensed in a unit-dose form and mustbe labeled with the patient's name, medical record number, the name of the narcotic, the dosage, the route of administration, and the frequency of administration.3. Verification of the medication. The pharmacist must verify the medication before dispensing it to the patient. The pharmacist must check the medication against the order to ensure that the correct medication is being dispensed.4. Counseling the patient. The pharmacist must counsel the patient on the safe use of the narcotic medication. The pharmacist must explain the risks and benefits of the medication, how to take the medication, and how to store the medication.5. Dispensing the medication. The pharmacist must dispense the narcotic medication to the patient. The pharmacist must give the patient the medication in a sealed container and must provide the patient with written instructions on how to take the medication.6. Documentation. The pharmacist must document thedispensing of the narcotic medication in the patient's medical record. The documentation must include the date of the dispensing, the name of the narcotic, the dosage, the route of administration, the frequency of administration, and the name of the patient.中文回答:住院药房麻醉药品发放流程。

应用 CPRIW 模式降低住院患者用药错误发生率

应用 CPRIW 模式降低住院患者用药错误发生率

应用 CPRIW 模式降低住院患者用药错误发生率介绍随着医疗水平的不断提高,住院患者的用药安全问题逐渐引起广泛关注。

用药错误不仅对患者的健康产生负面影响,还可能导致医疗成本的增加和医疗资源的浪费。

CPRIW(Critical Pathway for Reducing Inpatient Medication Errors)模式作为一种新的管理工具,能够有效降低住院患者用药错误的发生率。

本研究旨在探讨 CPIRW 模式在住院患者用药管理中的应用及其效果。

用药错误是指在用药过程中,因医务人员的失误、沟通不良、信息不全等原因导致的用药不当现象。

根据统计数据,住院患者中用药错误的发生率高达10% 至20%,严重影响患者的治疗效果和安全性。

因此,引入有效的管理模式对于降低用药错误至关重要。

CPRIW 模式通过整合医院内各部门资源,优化用药流程,以期在实际应用中降低住院患者的用药错误发生率。

CPRIW 模式概述CPRIW 模式的定义CPRIW 模式是一种系统化的用药管理模式,其核心理念是通过跨部门协作、流程优化和技术支持,提高用药安全性,减少用药错误。

CPRIW 代表了以下五个关键组成部分:1. 沟通(Communication):确保医务人员之间、医务人员与患者之间的有效沟通,减少信息传递中的误解与遗漏。

2. 路径(Pathway):制定标准化的用药路径,明确每一步的责任和流程。

3. 资源(Resources):合理配置医院内外部资源,确保用药过程中的人力和物力支持。

4. 信息技术(Information Technology):运用信息技术手段,如电子病历、临床决策支持系统等,提升用药管理的效率和准确性。

5. 监测(Monitoring):对用药过程进行动态监测,及时发现并纠正用药错误。

CPRIW 模式的实施步骤1. 组建多学科团队:由药师、医生、护士等组成的团队共同参与,用于制定和优化用药路径。

2. 制定标准化流程:根据患者具体情况,结合临床指南,制定个性化的用药标准化流程。

住院患者药学监护率目标值

住院患者药学监护率目标值

住院患者药学监护率目标值英文回答:Target Inpatient Medication Monitoring Coverage Rate.The target inpatient medication monitoring coveragerate is a key performance indicator (KPI) used to assessthe quality of medication management in hospitals. It measures the proportion of hospitalized patients whoreceive comprehensive medication monitoring services, which include:Medication reconciliation upon admission and discharge.Regular medication reviews.Monitoring for adverse drug events (ADEs) andpotential drug interactions.Patient education and counseling on medication use.The target coverage rate for inpatient medication monitoring varies depending on the healthcare setting andthe specific patient population. However, mostorganizations aim for a target rate of at least 80%. This target is based on evidence that comprehensive medication monitoring can significantly improve patient safety, reduce medication errors, and lower hospital costs.Several factors can impact the inpatient medication monitoring coverage rate, including:Hospital resources and staffing levels.Patient acuity and complexity.The availability of clinical decision support tools.The implementation of electronic health records (EHRs)。

某院住院药房不合理用药医嘱分析及干预措施

某院住院药房不合理用药医嘱分析及干预措施

某院住院药房不合理用药医嘱分析及干预措施韩静文;耿魁魁;刘圣【摘要】目的分析该院临床不合理用药医嘱情况,为临床安全、有效、合理用药提供参考.方法对2015年7月—2016年7月住院药房不合理用药医嘱进行统计分析.结果不合理医嘱共9408条,占总医嘱的1.94%,类型包括药物配伍不合理、溶剂选择不合理、给药剂量不合理、药物浓度不合理、给药频次不合理、给药途径不合理与录入错误.结论通过对静脉医嘱进行审核和干预,能及时发现并纠正临床不合理用药现象,促进临床合理用药.%Objective To analyze the situation of the irrational medication orders in our hospital and to provide reference for clinical safe,effective and rational drug use. Methods The irrational medication orders of the inpatient pharmacy in Department of Pharmacy, Anhui Provincial Hospital from July 2015 to July 2016 were analyzed statistically. Results There were 9408 irrational medication or-ders,accounting for 1. 94% ,including drug incompatibility,irrational solvent,irrational dose,irrational concentration,irrational medica-tion frequency and entry errors. Conclusions The review and intervention on the medication orders,able to discover and correct irra-tional drug use can promote the clinical rational medication.【期刊名称】《安徽医药》【年(卷),期】2017(021)011【总页数】4页(P2097-2100)【关键词】不合理医嘱;合理用药;干预【作者】韩静文;耿魁魁;刘圣【作者单位】安徽省立医院南区药剂科,安徽合肥 230036;安徽省立医院南区药剂科,安徽合肥 230036;安徽省立医院南区药剂科,安徽合肥 230036【正文语种】中文在临床治疗中,医嘱用药的合理性直接关系到患者的疗效和生命安全,医护人员如果不了解药品正确的用法用量,给药途径及配伍禁忌等,就可能出现不合理医嘱,不合理医嘱可能会影响疗效,甚至引起药品不良反应[1]。

我院住院药房药品调剂流程

我院住院药房药品调剂流程

我院住院药房药品调剂流程英文回答:Inpatient Pharmacy Medication Dispensing Process.1. Medication Orders.Medications are ordered by physicians through the electronic medical record (EMR).Orders include the patient's name, medication name, dosage, frequency, route of administration, and any special instructions.2. Order Entry.Pharmacy technicians enter the medication orders into the pharmacy computer system.The system checks for drug-drug interactions,allergies, and other potential problems.If any issues are identified, the pharmacist is notified for review.3. Medication Preparation.Pharmacy technicians prepare the medications according to the physician's orders.This may involve counting tablets, filling vials, or preparing injections.All medications are labeled with the patient's name, medication name, dosage, and administration times.4. Medication Dispensing.Nurses dispense the medications to patients at the prescribed times.Nurses verify the patient's identity and themedication order before administering the medication.They also provide patient education on the medication, including how to take it, side effects, and precautions.5. Medication Administration.Patients take their medications as directed by the nurses.Nurses monitor patients for any adverse reactions or side effects.6. Medication Reconciliation.Upon admission to the hospital, the inpatient pharmacy performs a medication reconciliation to ensure that the patient's home medications are included in the hospital medication regimen.This helps to prevent medication errors and ensurethat patients receive the correct medications.7. Discharge Planning.The inpatient pharmacy provides patients with discharge instructions on their medications.This includes the medication name, dosage, frequency, and administration times.Patients are also counseled on any potential side effects or precautions.中文回答:住院药房药品调剂流程。

我国医疗机构重点监控药品监测平台合理应用管理指标的探讨

我国医疗机构重点监控药品监测平台合理应用管理指标的探讨

我国医疗机构重点监控药品监测平台合理应用管理指标的探讨作者:王笛王相峰毛丽超熊伟赵靖来源:《中国药房》2021年第08期中图分类号 R95 文献标志码 A 文章编号 1001-0408(2021)08-0911-04DOI 10.6039/j.issn.1001-0408.2021.08.03摘要目的:探讨重点监控药品监测平台的合理应用管理指标,为提高重点监控药品临床应用管理水平提供参考。

方法:采用文献研究和专家论证的方法,提出医疗机构重点监控药品的指标。

结果与结论:最终明确了医疗机构采购前20位药品目录、重点监控药品采购品规数、住院患者重点监控药品使用率、重点监控药品收入占比、住院患者重点监控药品费用增幅、住院患者单个重点监控药品费用增幅、住院患者重点监控药品次均费用增幅、使用重点监控药品的医嘱点评比例等8项重点监控药品通用性指标,以及医疗机构基本情况、病案首页、住院患者用药数据、医疗机构药品采购数据等4项数据采集项目。

综上,建立的医疗机构重点监控药品监测平台可为提高重点监控药品临床应用管理提供参考。

关键词重点监控药品;监测平台;数据采集;合理用药Discussion on the Monitoring Platform of Rational Use Management Indexes of Key Monitored Drugs of Medical Institutions in ChinaWANG Di1,WANG Xiangfeng2,MAO Lichao2,XIONG Wei3,ZHAO Jing1(1. National Center for Medical Service Administration,National Health Commission of the People’s Republic of China, Beijing 100810, China; 2. Dept. of Pharmacy, the First Hospital of Jilin University,Changchun 130031, China; 3. Dept. of Clinical Engineering and Information Technology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China)ABSTRACT OBJECTIVE: To discuss the monitoring platform of rational use management indexes of key monitored drugs, and to provide reference for improving their clinical application management. METHODS: The method of literature research and expert demonstration was adopted, the indexes of key monitored drugs in medical institutions were put forward. RESULTS & CONCLUSIONS: Finally, Eight general indexes as the list of top 20 drugs purchased by medical institutions, the specifications of key monitored drugs purchased, the utilization rate of key monitored drugs of inpatient, the proportion of key monitored drugs revenue, the increase in the cost of key monitored drugs of inpatient, the increase in the cost of key monitored drug of singleinpatient, the increase of the cost per time of key monitored drugs of inpatient, the proportion of doctor’s order review for key monitored drugs were defined. Four major data acquisition projects as the general information of medical institutions, medical record homepage, inpatient medication data, and medical institution drug procurement data were also defined. The monitoring platform of key monitored drugs in medical institutions can provide reference for improving the management of clinical application of key monitored drugs.KEYWORDS Key monitored drugs; Monitoring platform; Data acquisition; Rational drug use近年來,随着我国医疗卫生体制改革的深化,如何应对医保控费、取消药品加成等措施对医疗机构管理的影响,如何加强合理用药的管理、减轻患者的经济负担,已经成为大众关注的问题。

住院患者用药医嘱点评分析与干预措施

住院患者用药医嘱点评分析与干预措施

住院患者用药医嘱点评分析与干预措施摘要】目的:分析住院患者用药医嘱存在的问题,讨论干预措施以促进合理用药。

方法:抽取2018年1月—12月出院患者用药医嘱共480份,对用药合理性进行回顾性分析。

结果:不合理用药医嘱185份,占38.54%。

主要包括适应症不适宜117份,占63.24%、用法用量不适宜55份,占29.73%)和联合用药不适宜的13份,占7.03%等方面。

结论:通过临床药师医嘱点评,提高住院患者医嘱用药合理性。

【关键词】住院医嘱;处方点评;合理用药【中图分类号】R969.3 【文献标识码】A 【文章编号】2095-1752(2020)07-0022-02Review inpatients’ medication order and intervention approachGao Yan,Hao Zhihui,Li Yuanhui,Liu Peijing,Lu JingDepartment of Pharmaceutical,Jinchang Central Hospital,Jinchang,Gansu 737100,China【Abstract】Objective To review the intervention for irrational drug use for inpatients’ medication order by clinical pharmacists, improve the level of rational drug use.Methods Clinical pharmacists extracted inpa tients’ medication order from Jan. to Dec.2018 totally 480 medical orders were included. Retrospective analysis was conducted on the rationality of medical orders. Results 185 pieces were irrational, accounting for 38.54%. There were 185 cases with irrational drug use, mainly performed as improper indications medication(117 cases,63.2% ),improper dosage and usage (55 cases,29.8%),improper drug combination (13cases,7.0%).Conclusion Through the clinical pharmacists’ review and intervention,the proportion of rational inpatient’s medication orders can be further improved.【Key words】Inpatient’s medication orders; Prescription review; Rational medication处方是指由医师在诊疗活动中为患者开具的、由药师审核、调配、核对,并作为患者用药凭证的医疗文书,处方包括病区用药医嘱单。

英文病历书写要求

英文病历书写要求

原文来自:湘雅医学翻译网MEDICAL RECORD DOCUMENTATIONIncomplete inpatient medical record documentation will be identified by UTMB staff. Y ou will receive written notification of your incomplete record documentation on a weekly basis through U.S. Postal Service mail. UTMB Bylaws and Rules & Regulations of the Medical Staff state that “no record shall remain incomplete, including signatures, greater than thirty (30) calendar days from discharge”.Final Discharge Note (Form 5346)The Final Discharge Note should be completed at the time of discharge. It should be signed (full signature) and dated by the attending physician. Abbreviations should not be used on this form. The following must be recorded on the form:Principal Diagnosis: The condition which, after study, caused admission to the hospital.Complications (if present): Conditions which developed after admission that may have extended the length of stay and required use of additional resources.Comorbidities (if existing): Conditions present prior to admission that could extend the length of stay or require additional resources.Principal Procedure: The definite/therapeutic procedure most closely related to the principal diagnosis.The discharge plan must be documented, and the availability of appropriate services to meet the patient’s needs after hospitalization must be addressed.History and Physical Examination (Form 2005)A complete history and physical examination shall, in all cases, be written and placed in the record within twenty-four (24) hours after admission of the patient. If a complete history and physical has been obtained within thirty (30) days prior to admission in a physician’s office, a durable legible copy of this report may be used in the patient’s hospital medical record, provided there have been no subsequent changes or if there were changes, the changes have been recorded at the time of admission. A durable, legible original or reproduction of the office or clinical prenatal record is acceptable.The history and physical examination includes at a minimum the patient’s chief complaint, present illness/injury, review of systems, past history, family history and physical examination. The patient’s biophysical, psychosocial, cultural, spiritual, developmental, educational, functional,nutritional, and pain/comfort needs will be addressed as appropriate. The physician H&P will be filed in the H&P section of the medical record.The attending physician must sign and date the History and Physical Examination.Inpatient Progress Note (Form 5300)Inpatient progress notes shall be written to provide a chronological record of the patient’s progress. Notes should be timely, legible, relevant, and sufficiently detailed to permit and justify continuity of care. Progress notes on procedures/operations should also include doctor number after the signature. All notes must be timed, dated and signed. A progress note should be written by a physician everyday and more often on critical patients.Operative ReportAn operative note must be written and dictated immediately after surgery and should include the items listed below. The report is signed by the appropriate physician(s).1.preoperative diagnosis;2.postoperative diagnosis; of procedure;4.description of findings;5.technical procedure used;6.specimens removed; of primary surgeon and any assistants; and8.condition of patient after surgery.Discharge SummaryA discharge summary is required on patients discharged from the hospital and should be completed at the time of discharge.The Discharge Summary must contain:, UH#, date of admission, date of discharge, and attending physician;2.chief complaint or reason(s) for admission;3.significant history and physical findings;4.pertinent laboratory and x-ray findings;5.treatment rendered;6.princ ipal and additional or associated diagnoses (indicate principal);7.surgical procedures; and8.disposition –include specific instructions given to the patient and/or family, aspertinent (including instructions relating to physical activity, medication, diet, andfollow-up care);9.prognosis.The physician is required to sign and date the discharge summary.Dictated/typed discharge summaries are not required in the following situations:1.normal obstetric deliveries, including uncomplicated cesarean sections;2.normal newborns.see:/Article/ShowArticle.asp?ArticleID=851。

临床试验常用术语及缩略语

临床试验常用术语及缩略语

临床试验常用术语及缩略语监管机构和法规相关◆NMPA国家药品监督管理局(National Medical Products Administration)◆CDE国家药品监督管理局药品审评中心(CENTER FOR DRUG EVALUATION,NMPA)◆国家药品不良反应监测中心(National Center for ADR Monitoring,China)◆GCP药物临床试验质量管理规范(Good Clinical Practice)◆GMP药品生产质量管理规范(GoodManufacturingPractice)◆GLP药物非临床研究质量管理规范(Good Laboratory Practice of drug)◆ICH人用药品注册技术要求国际协调会议(InternationalConference on Harmonization)◆ICH GCP:指导原则的目的是为欧盟、日本和美国提供统一的标准,以促进这些管理当局在其权限内相互接受临床数据。

本指导原则的发展考虑了欧盟、日本、美国,以及澳大利亚、加拿大、北欧国家和世界卫生组织(GCP)的现行GCP。

◆WHO世界卫生组织(World Health Organization)◆FDA美国食品与药品管理局(Food and Drug Administration)文件相关◆CTP临床试验方案(Clinical Trial Protocol):指说明临床试验目的、设计、方法学、统计学考虑和组织实施的文件。

试验方案通常还应当包括临床试验的背景和理论基础,该内容也可以在其他参考文件中给出。

试验方案包括方案及其修订版。

◆SOP标准操作规程(Standard Operating Procedure):指为保证某项特定操作的一致性而制定的详细的书面要求。

◆TMF试验主文件夹/研究管理文件夹(Trial Master File)◆IB研究者手册(Investigator’s Brochure):指与开展临床试验相关的试验用药品的临床和非临床研究资料汇编。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

2273Am J Health-Syst Pharm—Vol 65 Dec 1, 2008n o t eT racey L. M ersfeLder , P harM .d., BcPs, is Associate Professor, College of Pharmacy, Ferris State University, Big Rapids, MI. r yan J. B ickeL , P harM .d., is Clinical Pharmacy Specialist, Borgess Medical Center, Kalamazoo, MI.Address correspondence to Dr. Mersfelder at the College of Phar-macy, Ferris State University, 220 Ferris Drive, Big Rapids, MI 49307 (traceymersfelder@).Presented at the ASHP Midyear Clinical Meeting, Las Vegas, NV, December 4, 2007.The authors have declared no potential conflicts of interest.Copyright © 2008, American Society of Health-System Pharma-cists, Inc. All rights reserved. 1079-2082/08/1201-2273$06.00.DOI 10.2146/ajhp080013Inpatient medication history verification by pharmacy studentsT racey L. M ersfeLder and r yan J. B ickeL Purpose. The ability of pharmacy students to improve the accuracy of patients’ medi-cation histories was studied.Methods. This prospective study was con-ducted between January and April 2007 at a 424-bed community teaching hospital. Pharmacy students were assigned one ortwo patients daily admitted to the inpa-tient internal medicine service and were required to perform a thorough medication history for each. Patients were included in the study if a medication history was performed and recorded on the medica-tion reconciliation form. Students were instructed to obtain medication historiesby interviewing the patient, a family mem-ber, or both and calling the patient’s com-munity pharmacy to verify all medications. If there were any discrepancies between these sources of information and the initial medication reconciliation form, the infor-mation was reconfirmed with the patient. Any information obtained by the studentsthat had not already been documented on the medication reconciliation record was updated in the patient’s chart. Results. A total of 326 charts were included in this analysis. Student-obtained medica-tion histories resulted in the addition of previously undocumented prescription medications to 175 charts (53.7%) and nonprescription medications or natural products to 167 charts (51.2%). Calling the patients’ community pharmacy helped to identify omissions or discrepancies approximately 75% of the time. Overall, the students improved the accuracy of medication histories for 220 (67%) of the 326 patients.Conclusion. Pharmacy students’ participa-tion in obtaining medication histories im-proved the completeness and accuracy of patient medication records.Index terms: Patient information; Phar-maceutical services; Pharmacy; Pharmacy, institutional, hospital; Quality assurance Am J Health-Syst Pharm. 2008; 65:2273-5O btaining medication histories has been an important func-tion performed by pharmacists since the 1970s.1-3 The collection of thorough medication histories is time-consuming, and these histories are usually obtained by physicians and nurses. Subsequent to the Joint Commission’s mandate that an ac-curate medication list be included in every patient’s profile,4 many hospitals are researching innovative ways to obtain accurate medication histories. Some institutions have investigated the use of supervised pharmacy students for providing assistance in verifying medication histories and updating medication reconciliation forms.5-9 The objec-tives of this study were to determine the frequency of discrepancies dis-covered and corrected by pharmacystudents and to determine if tele-phoning the patients’ communitypharmacy was valuable in obtainingaccurate information.Methods A prospective study was conduct-ed between January and April 2007 at a 424-bed community teaching hos-pital after receiving permission from the investigational review board.Pharmacy students who participated in performing verifications of medi-cation histories were completing aninternal medicine rotation. Studentswere prepared for study participationbefore beginning the rotation by at-tending a three-hour didactic lecture and obtaining a mock medication history of a family member, which was formally critiqued. In addition, students received oral and written in-structions on performing medication histories and a standardized medica-note Medication history 2274Am J Health-Syst Pharm—Vol 65 Dec 1, 2008tion history form during orientation of the rotation.One or two patients were ran-domly assigned to the students daily, depending on the census of the in-patient internal medicine service. Patients were included in the study if a medication history was obtained and recorded on the medication reconciliation form. The medication reconciliation form at this institu-tion is generally completed by physi-cians, physician assistants, nurses, or nursing assistants. Students were instructed to obtain medication his-tories by interviewing the patient, a family member, or both and calling the patient’s community pharmacy to verify all medications. If there were any discrepancies between these sources of information and the initial medication reconciliation form, the information was reconfirmed with the patient. Each patient’s medica-tion history was then reviewed with a preceptor for accuracy. In addi-tion, preceptors randomly observed patient interviews to ensure quality. If needed, any new information was documented in the patient’s chart. Discrepancies were recorded by the investigator on a data collection sheet.ResultsA total of 346 charts were re-viewed by seven students. Twenty charts were excluded from the study. Three charts were excluded because they were not from internal medi-cine patients, and 17 were excluded because a medication reconciliation form had not been completed for comparison. For excluded patients, a medication history had still been obtained by the students and inter-ventions were noted in the chart, if needed.The remaining 326 charts were included in the analysis. Student- obtained medication histories re-sulted in the addition of previ-ously undocumented prescription medications to 175 charts (53.7%) and nonprescription medications or natural products to 167 charts (51.2%). A total of 440 prescription medications and 414 nonprescrip-tion medications or natural products were documented, for an average of 1.35 prescription medications and 1.27 nonprescription medications or natural products per chart. An overview of the types of previously undocumented prescription medi-cations reported by the pharmacy students is provided in Table 1. A summary of prescription medi-cation additions and clarifications made by the students is provided in Table 2. Of the 326 charts included in the analysis, 307 included 2270 prescription medications. This was an average of 7.39 medications per chart. The students clarified dos-age information in over 30% of the completed medication reconcilia-tion forms. Over 67% of the patient charts had either a medication or a dosage omitted that was clarified by the pharmacy students. The students conducted 316 patient interviews and telephoned 312 of the patients’ community pharmacies. Calling the pharmacy helped identify omissions or discrepancies approximately 75% of the time. The students’ interven-tions were communicated throughnote Medication history 2275Am J Health-Syst Pharm—Vol 65 Dec 1, 2008documentation in the patients’ charts, as applicable.Discussion The eighth National Patient Safety Goal established by the Joint Com-mission is to “accurately and com-pletely reconcile medications across the continuum of care.”4 This has peaked the interest of clinicians and administrators in finding ways to obtain accurate medication his-tories over the past few years. It is important to obtain the most accu-rate medication history possible to prevent medication errors. Unfortu-nately, medication histories are time-consuming to obtain, and health care systems have limited resources. Pharmacy students are frequently placed in health care systems to gain training but can actively contribute to patient care by performing accu-rate, thorough medication histories. In this study, the pharmacy students demonstrated that they can contrib-ute to the accuracy of the medication histories available to other health care providers. They identified medi-cations that were omitted from the original medication histories in over 50% of the charts. In addition, they reconciled dosage information that had been omitted in approximately 30% of the charts.The published data from other institutions regarding medication histories obtained by pharmacy stu-dents were only available in abstract form at the time of writing; therefore, it is difficult to compare our results with those of other facilities.5-9 How-ever, all of the authors reported that pharmacy students contributed to the overall information provided, with 15–75% of patients’ charts up-dated and 3–85% of medications rec-onciled.5-7 Also, authors of one study reported that pharmacy students were able to add a mean of one medi-cation previously unreported per patient chart.9 Our data were consis-tent with these ranges. The authorsof one study that included the use of pharmacy students determined that 57% of the medication histories had omissions.10 In addition, over 30% of the medication histories contained differing information, which is also similar to our findings. Our results do not correlate with those of Carter and colleagues,11 who aimed to identify discrepancies between medication histories taken by emergency department staff and a clinical pharmacist. They reported the rate of medication omissions as 25% and the rate of dosage in-formation missing as 78%. One ex-planation for a lower rate of dosage information omissions in our study is that the students obtained the medication histories the morning af-ter admission. This allowed time for other disciplines and departments to help with the reconciliation before the students obtained the medica-tion histories. Our rate of omitted medications may be higher because the students telephoned over 95% of the patients’ community pharmacies. Carter et al. did not state how often pharmacies or physician offices were contacted.The most significant limitation to our study was the inability to deter-mine whether the students’ medica-tion histories were 100% complete. There is not a standard mechanism to determine this, especially for non-prescription and natural products. It is also difficult to apply these results to the entire institution due to the sample population (inpatient inter-nal medicine service) and student availability (only 14–18 students are assigned to the institution an-nually). Lastly, preceptors are not assigned pharmacy students two to four months of the year; however, the students assigned have continued to provide this service when available.Conclusion Pharmacy students’ participation in obtaining medication histories improved the completeness and accuracy of patient medication records. References 1. La Verde S. Evaluation of drug history program. Hospitals. 1973; 47:106 passim. 2. Covington TR, Pfeiffer FG. The pharmacist-acquired medication history. Am J Hosp Pharm. 1972; 29:692-5.3. Wilson RS, Kabat HF. Pharmacist initi-ated patient drug histories. Am J Hosp Pharm. 1971; 28:49-53.4. Joint Commission. 2007 Hospital/Critical Access Hospital National Patient Safety Goals. /PatientSafety/NationalPatientSafety Goals/07_hap_cah_npsgs.htm (accessed 2008 Aug 27).5. Fujisaki BS, Farthing K, Marcus KB. Iden-tifying and resolving potential medica-tion errors in hospital admission orders. Paper presented at ASHP Midyear Clini-cal Meeting. Atlanta, GA; 2002 Dec 10.6. Roth KB, McCoy LK, Hill S et al. Achiev-ing patient safety through medication reconciliation: a pilot. Paper presented at ASHP Midyear Clinical Meeting. Las Vegas, NV; 2005 Dec 5.7. Padiyara RS, Rabi SM. Pharmacy students and reconciliation of medication upon hospital admission. Paper presented at ASHP Midyear Clinical Meeting. Ana-heim, CA; 2006 Dec 5.8. Mashni SM, Carroll WW. Medication reconciliation begins with pharmacy students in the emergency department. Paper presented at ASHP Midyear Clini-cal Meeting. Las Vegas, NV; 2007 Dec 4.9. Jungst DW, Gonzalez FJ. Medication histories and medication reconciliation utilizing pharmacy students: a pilot study. Paper presented at ASHP Midyear Clini-cal Meeting. Las Vegas, NV; 2005 Dec 8.10. Lessard S, DeYoung J, Vazzana N. Medi-cation discrepancies affecting senior patients at hospital admission. Am J Health-Syst Pharm. 2006; 63:740-3. 11. Carter MK, Allin DM, Scott LA et al. Pharmacist-acquired medication histo-ries in a university hospital emergency department. Am J Health-Syst Pharm. 2006; 63:2500-3.。

相关文档
最新文档